Thinly traded nano cap vTv Therapeutics (VTVT +121.6%) rockets on a whopping 121x surge in volume.
The company just filed an 8-K disclosing that top investor MacAndrews & Forbes Group, controlled by noted investor Ronald Perelman, just bought another 1,879,699 Class A common shares at $1.33 per share pursuant to a July 30 agreement. Its stake is now over 36M shares.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.